e-Drug3D

1345

cas 62-90-8

CLASS

HORMONES
ANDROGENIC
AGONIST
ANABOLIC STEROID

ROUTE (list)

INJECTION

PK parameters

MW 406.54
NB_atoms 30
XLogP 5.67
PSA 41.545
NB_HD 0
NB_HA 3
fsp3 0.63
Lipinski(0=no;1=yes) 0

FDA
NDA 086386 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 087488 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089297 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089298 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 011891 (pdf not found) INN (NANDROLONE PHENPROPIONATE) DURABOLIN (ORGANON USA INC) APPROVAL= AP YEAR= 1959 NEWMOLECULARENTITY DISCONTINUED

e-Drug3D

262

cas 434-22-0

CLASS

METABOLISM
ANABOLIC
ANDROGENS

ROUTE (list)

-

PK parameters

Tmax 72 HOUR (PMID15713722)
Cmax 18.8 NANOMOLAR
t1/2 228 HOUR

TARGET ANDROGEN RECEPTOR

PDB
5KP4 (CRYSTAL STRUCTURE OF KETOSTEROID ISOMERASE FROM PSEUDOMONAS PUTIDA (PKSI) BOUND TO 19-NORTESTOSTERONE)

Ligand code = 6VW (link to the list of PDB complexes)

Download experimental 3D coordinates of 6VW with added hydrogens

MW 274.39
NB_atoms 20
XLogP 3.49
PSA 37.763
NB_HD 1
NB_HA 2
fsp3 0.83
Lipinski(0=no;1=yes) 1

FDA
-